Keytruda is not chemotherapy. It’s a type of treatment called immunotherapy. It works with the body’s immune system, helping T cells fight cancer cells. With immunotherapy, the body’s immune system ...

**Note: UNM allowed limited access to the parking structure on Thursday, one day after this story originally was published. ALBUQUERQUE, N.M. (KRQE) – A Lobo Alert went out Wednesday morning, ...

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...

Around 11:15 a.m., Leonidas Fire Department (LFD) and Mendon Fire Department crews were called to Jacksonburg Road near Smith Road for a "single-story structure" emitting heavy smoke, according to LFD ...

The U.S. 5th Circuit Court of Appeals Tuesday ruled that the National Labor Relations Board's structure is likely unconstitutional and barred the federal agency from pursuing cases against SpaceX and ...

A federal appeals court handed SpaceX a win on Tuesday, in a ruling that prevents the National Labor Relations Board from prosecuting unfair labor practices against the company. The ruling by the U.S.

Pfizer's pipeline in oncology, combined with its cost-cutting initiatives, could help it bounce back. Merck could move beyond Keytruda thanks to newer approvals and a novel formulation of the medicine ...

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a world without President Trump’s tariffs. By Rebecca Robbins President ...

Keytruda and Padcev combination improved survival in muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy. The KEYNOTE-905 trial showed significant event-free survival ...

The rising bladder cancer star that is the combination of Pfizer and Astellas’ Padcev and Merck’s Keytruda is looking to set a new standard in another patient group after proving its prowess as a pre- ...

The Keytruda-Padcev combo improved event-free and overall survival in the Phase 3 trial. No new safety issues were found; Merck will present the results at the medical meeting. Want to trade this news ...